The European Medicines Agency has accepted only four of the 15 applications received so far under its early interaction pilot, which offers free scientific advice to drug companies in an effort to stimulate pediatric development1,2.
While two applications are currently under discussion regarding acceptability, six applications were rejected, two were withdrawn and one was integrated...




